KMBMEDIUM SIGNALFINANCIAL10-K

Kimberly-Clark reported broad-based financial declines with revenue falling 18% and operating income dropping 27% year-over-year.

The company experienced meaningful contractions across key operational metrics, suggesting either challenging market conditions or potential execution issues that require monitoring. The substantial reduction in share buybacks from $1.0B to $141M indicates management is prioritizing cash preservation over shareholder returns.

Comparing 2026-02-12 vs 2025-02-13View on EDGAR →
FINANCIAL ANALYSIS

KMB's financial performance weakened notably with revenue declining 18% to $16.4B and operating income falling 27% to $2.4B, while gross profit margins compressed. Despite the operational headwinds, stockholders' equity grew substantially to $1.5B, though this was accompanied by higher debt levels and reduced cash positions. The dramatic pullback in share repurchases suggests management is taking a more conservative capital allocation approach amid the challenging operating environment.

FINANCIAL STATEMENT CHANGES
Share Buybacks
Cash Flow
-85.9%
$1.0B$141.0M

Buyback activity reduced 85.9% — capital being redeployed elsewhere or cash conservation underway.

Stockholders Equity
Balance Sheet
+78.8%
$840.0M$1.5B

Equity base grew 78.8% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Cash & Equivalents
Balance Sheet
-32.6%
$1.0B$688.0M

Cash declined 32.6% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Operating Income
P&L
-26.8%
$3.2B$2.4B

Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.

Net Income
P&L
-20.6%
$2.5B$2.0B

Net income declined 20.6% — review whether driven by operations, interest costs, or non-recurring items.

Inventory
Balance Sheet
-19%
$1.8B$1.5B

Inventory reduced 19% — lean inventory management or demand outpacing supply.

Revenue
P&L
-18%
$20.1B$16.4B

Revenue softened 18% — monitor whether this is cyclical or structural.

Gross Profit
P&L
-17.5%
$7.2B$5.9B

Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.

Operating Cash Flow
Cash Flow
-14.1%
$3.2B$2.8B

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

Total Debt
Balance Sheet
+10.4%
$6.7B$7.4B

Debt rose 10.4% — additional borrowing for investment or operations; monitor coverage ratios.

LANGUAGE CHANGES
NEW — 2026-02-12
PRIOR — 2025-02-13
ADDED
As of January 30, 2026, there were 331,922,371 shares of Kimberly-Clark common stock outstanding.
Management's Discussion and Analysis of Financial Condition and Results of Operations 23 Item 7A.
Form 10-K Summary 94 Signatures 95 KIMBERLY-CLARK CORPORATION - 2025 Annual Report PART I ITEM 1.
We are a global company focused on delivering essential products and solutions that solve unmet consumer needs and provide Better Care for a Better World.
Kimberly-Clark and our trusted brands are an indispensable part of life for people in more than 175 countries and territories.
+7 more — sign up free →
REMOVED
As of January 31, 2025, there were 331,684,601 shares of Kimberly-Clark common stock outstanding.
Management's Discussion and Analysis of Financial Condition and Results of Operations 17 Item 7A.
Form 10-K Summary 81 Signature s 82 KIMBERLY-CLARK CORPORATION - 2024 Annual Report PART I ITEM 1.
We are a global company focused on delivering products and solutions that provide better care for a better world through product innovation and building o ur brands.
Fueled by ingenuity, creativity, and an understanding of people's most essential needs, we create products that help individuals experience more of what's important to them.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →